News

Kenvue Stock Has Unusual Put Option Activity After Lower Q2 Sales and CEO Firing
Aid, Listerine, Neutrogena, and Johnson's consumer products, reported disappointing Q2 sales and just announced that its CEO ...
Kenvue: New CEO, Watch The Dividend (Rating Downgrade)
“The Board’s strategic review is underway, and we are considering a broad range of potential alternatives, including ways to ...
Medical Marketing & Media3h
The Escalator: Johnson & Johnson MedTech, Jazz Pharmaceuticals, Kenvue and more
Inventiva named Jason Campagna as president of R&D and chief medical officer, and Martine Zimmermann as EVP of regulatory affairs and quality assurance. Evolent named Dr. David Lim as chief clinical ...
Stock Movers: Coinbase, Autodesk, Kenvue
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Business Wire3d
Kenvue Announces CEO Transition and Actions to Unlock Shareholder Value
Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors is implementing a set of actions to enable the Company ...
Barchart on MSN1d
Kenvue's Q2 2025 Earnings: What to Expect
Skillman, New Jersey-based Kenvue Inc. (KVUE) operates as a global consumer health company. Valued at $41.9 billion by market ...
Kenvue Inc. stock falls Tuesday, underperforms market
The stock's fall snapped a four-day winning streak.
6KVUE : Assessing Kenvue: Insights From 6 Financial Analysts
The 12-month price targets, analyzed by analysts, offer insights with an average target of $23.58, a high estimate of $25.00, ...